But : stratifier le risque cardiaque via l’utilisation de biomarqueurs sériques

First Page		Document Content
Date: 2010-10-28 05:51:07 Heart diseases Peptide hormones RTT Brain natriuretic peptide Cardiology Biomarkers N-terminal prohormone of brain natriuretic peptide Heart failure Pulmonary embolism Diastolic heart failure Atrial natriuretic peptide		But : stratifier le risque cardiaque via l’utilisation de biomarqueurs sériques Add to Reading List Source URL: www.comites-d-interface.inserm.fr Download Document from Source Website File Size: 2,43 MB Share Document on Facebook

	American Society of Hematology Ten Things Physicians and Patients Should Question Don’t transfuse more than the minimum number of red blood cell (RBC) units necessary to relieve symptoms of anemia or to return a patie DocID: 1qEzi - View Document
	OUTPATIENT ANTICOAGULATION FLOWSHEET Adapted from AAFP - Adjust medications only under direction of your provider ----------------------------------------------------------------------------------------------------Patie DocID: 1pEDI - View Document
	Case Report Journal of Orthopaedic Case Reports 2016 April - June: 6(2):PageThe Popliteal Vein Thrombosis in A Pediatric Patient: A Case Report. DocID: 1poyF - View Document
	But : stratifier le risque cardiaque via l’utilisation de biomarqueurs sériques DocID: 1onpg - View Document
	Press Release UK’s NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults Tokyo, Japan (August 26, The National Insti DocID: 1lmge - View Document